ATA156187A - Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung - Google Patents

Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung

Info

Publication number
ATA156187A
ATA156187A AT0156187A AT156187A ATA156187A AT A156187 A ATA156187 A AT A156187A AT 0156187 A AT0156187 A AT 0156187A AT 156187 A AT156187 A AT 156187A AT A156187 A ATA156187 A AT A156187A
Authority
AT
Austria
Prior art keywords
ketotific
producing
composition
solid oral
oral pharmaceutical
Prior art date
Application number
AT0156187A
Other languages
English (en)
Other versions
AT400521B (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA156187A publication Critical patent/ATA156187A/de
Application granted granted Critical
Publication of AT400521B publication Critical patent/AT400521B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT0156187A 1986-06-21 1987-06-19 Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung AT400521B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3620830 1986-06-21

Publications (2)

Publication Number Publication Date
ATA156187A true ATA156187A (de) 1995-06-15
AT400521B AT400521B (de) 1996-01-25

Family

ID=6303418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0156187A AT400521B (de) 1986-06-21 1987-06-19 Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung

Country Status (30)

Country Link
US (1) US5399360A (de)
JP (2) JPS638332A (de)
KR (1) KR880000095A (de)
AT (1) AT400521B (de)
AU (1) AU611637B2 (de)
BE (1) BE1000661A4 (de)
CA (1) CA1314227C (de)
CH (3) CH672735A5 (de)
CY (1) CY1589A (de)
DE (1) DE3719818C2 (de)
DK (1) DK314387A (de)
ES (1) ES2006170A6 (de)
FI (1) FI872733A (de)
FR (1) FR2600253B1 (de)
GB (1) GB2191696B (de)
GR (1) GR870965B (de)
HK (1) HK27691A (de)
HU (1) HU202753B (de)
IE (1) IE59178B1 (de)
IL (1) IL82924A (de)
IT (1) IT1216822B (de)
LU (1) LU86928A1 (de)
MY (1) MY101566A (de)
NL (1) NL8701335A (de)
NO (1) NO872551L (de)
NZ (1) NZ220769A (de)
PH (1) PH26313A (de)
PT (1) PT85128B (de)
SE (1) SE8702563L (de)
ZA (1) ZA874450B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
US6207684B1 (en) 1997-06-09 2001-03-27 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
US6740889B1 (en) * 1998-09-28 2004-05-25 Applied Materials, Inc. Charged particle beam microscope with minicolumn
WO2001039774A1 (en) * 1999-12-01 2001-06-07 Klein Pharmaceuticals Topical administration of ketotifen
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ514536A (en) * 2001-09-28 2005-02-25 Meracol Corp Ltd Use of cetyl myristate and/or cetyl palmitate to treat asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
JP4867128B2 (ja) * 2002-10-01 2012-02-01 大正製薬株式会社 経口鼻炎治療用組成物
AU2005320547B2 (en) * 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
WO2008153761A1 (en) * 2007-05-23 2008-12-18 Mastcell Pharmaceuticals, Inc. Methods
WO2009142772A2 (en) * 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
EP2441445A1 (de) * 2010-10-14 2012-04-18 Deva Holding Anonim Sirketi Cetylmyristat- und/oder Cetylpalmitatteilchenbeschichtung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
DE2426811A1 (de) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab Verfahren zur herstellung von retard-tabletten
US4073915A (en) * 1975-05-20 1978-02-14 Sandoz Ltd. Treating asthma
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
WO1985003878A1 (en) * 1984-03-01 1985-09-12 Sandoz Ag Pharmaceutical compositions
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
IT1200102B (it) * 1984-08-16 1989-01-05 Sandoz Ag Preparazioni farmaceutiche comprendenti chetotifere ed una xartina ad azione antiasmatica in combinazione fissa
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule

Also Published As

Publication number Publication date
IE871634L (en) 1987-12-21
BE1000661A4 (fr) 1989-03-07
GB2191696A (en) 1987-12-23
CY1589A (en) 1992-04-03
JP2860013B2 (ja) 1999-02-24
FR2600253A1 (fr) 1987-12-24
GB8714131D0 (en) 1987-07-22
FR2600253B1 (fr) 1990-01-26
US5399360A (en) 1995-03-21
NO872551D0 (no) 1987-06-18
SE8702563L (sv) 1987-12-22
NZ220769A (en) 1990-12-21
AU611637B2 (en) 1991-06-20
KR880000095A (ko) 1988-03-23
IT1216822B (it) 1990-03-14
MY101566A (en) 1991-12-17
FI872733A (fi) 1987-12-22
CA1314227C (en) 1993-03-09
ES2006170A6 (es) 1989-04-16
CH672735A5 (de) 1989-12-29
PT85128B (pt) 1990-03-30
IL82924A0 (en) 1987-12-20
PT85128A (en) 1987-07-01
CH676201A5 (de) 1990-12-28
AT400521B (de) 1996-01-25
DK314387D0 (da) 1987-06-19
HUT47428A (en) 1989-03-28
NL8701335A (nl) 1988-01-18
JPH05246849A (ja) 1993-09-24
DE3719818C2 (de) 1997-02-13
JPS638332A (ja) 1988-01-14
CH674805A5 (de) 1990-07-31
DE3719818A1 (de) 1987-12-23
LU86928A1 (fr) 1988-01-20
GB2191696B (en) 1991-01-16
ZA874450B (en) 1989-01-25
IL82924A (en) 1992-11-15
HK27691A (en) 1991-04-19
DK314387A (da) 1987-12-22
IE59178B1 (en) 1994-01-26
PH26313A (en) 1992-04-23
NO872551L (no) 1987-12-22
GR870965B (en) 1987-10-20
FI872733A0 (fi) 1987-06-18
IT8748075A0 (it) 1987-06-19
SE8702563D0 (sv) 1987-06-18
AU7452587A (en) 1987-12-24
HU202753B (en) 1991-04-29

Similar Documents

Publication Publication Date Title
AT377438B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT381638B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur topischen applikation
ATA156187A (de) Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung
DE59008157D1 (de) Verfahren zur herstellung einer zahnprothese.
ATA170086A (de) Verfahren zur herstellung einer festen haltbaren darreichungsform
DE3865896D1 (de) Verfahren und mittel zur herstellung einer zahnbruecke.
ATA112385A (de) Verfahren zur herstellung wenigstens zweilagiger gegenstände
DE3679361D1 (de) Verfahren zur herstellung endossaler implantate.
DE3686350D1 (de) Verfahren zur herstellung einer chirurgischen klammer.
ATA164187A (de) Verfahren zur herstellung eines pharmazeutischen pulvers
DE3676741D1 (de) Verfahren zur herstellung endossaler implantate.
ATA151687A (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen)
ATA115186A (de) Verfahren zur herstellung eines pharmazeutischen praeparates mit gefaesschuetzender wirkung
AT399634B (de) Verfahren zur herstellung einer süssware
AT385659B (de) Verfahren zur herstellung einer therapeutischen zusammensetzung
DE3864334D1 (de) Heterogene kaugummi-zusammensetzung und verfahren zur zubereitung.
ATA903983A (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
AT385653B (de) Verfahren zur herstellung eines zahnputzmittels
DE3781767D1 (de) Verfahren zur herstellung einer extra-oralen zahnrestauration.
AT374682B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
ATA207887A (de) Verfahren zur herstellung eines pharmazeutischen nicorandilpraeparats zur perkutanen absorption
ATA137581A (de) Verfahren zur herstellung eines pharmazeutischen praeparates
ATA206287A (de) Verfahren zur herstellung einer backware
ATA206087A (de) Verfahren zur herstellung einer octreotid enthaltenden pharmazeutischen zusammensetzung
AT383272B (de) Verfahren zur herstellung von pharmazeutischen tabletten

Legal Events

Date Code Title Description
ELA Expired due to lapse of time